These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 15504309

  • 1. [Left ventricular mass and function in growth hormone deficient children and adolescents before and after one year of recombinant human growth hormone (GH) replacement therapy].
    Szczepańska Kostro J, Tołwińska J, Urban M, Głowińska B.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):75-80. PubMed ID: 15504309
    [Abstract] [Full Text] [Related]

  • 2. [Homocysteine levels in growth hormone deficient children and adolescents before and after one year of recombinant human growth hormone (GH) replacement therapy].
    Szczepańska J, Urban M, Głowińska B.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):87-92. PubMed ID: 15504311
    [Abstract] [Full Text] [Related]

  • 3. Cardiac mass and function, carotid artery intima media thickness, homocysteine and lipoprotein levels in children and adolescents with growth hormone deficiency.
    Szczepańiska Kostro J, Tołwińska J, Urban M, Gardziejczyk M, Głowińska B.
    J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1405-13. PubMed ID: 15526719
    [Abstract] [Full Text] [Related]

  • 4. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.
    Salerno M, Esposito V, Spinelli L, Di Somma C, Farina V, Muzzica S, de Horatio LT, Lombardi G, Colao A.
    Clin Endocrinol (Oxf); 2004 May; 60(5):630-6. PubMed ID: 15104568
    [Abstract] [Full Text] [Related]

  • 5. Effects of one year of recombinant human growth hormone (GH) therapy on cardiac mass and function in children with classical GH deficiency.
    Shulman DI, Root AW, Diamond FB, Bercu BB, Martinez R, Boucek RJ.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4095-9. PubMed ID: 12970269
    [Abstract] [Full Text] [Related]

  • 6. Effects of growth hormone therapy in children after cardiac transplantation.
    Mital S, Andron A, Lamour JM, Hsu DT, Addonizio LJ, Softness B.
    J Heart Lung Transplant; 2006 Jul; 25(7):772-7. PubMed ID: 16818119
    [Abstract] [Full Text] [Related]

  • 7. Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age.
    Feinberg MS, Scheinowitz M, Laron Z.
    Am Heart J; 2003 Mar; 145(3):549-53. PubMed ID: 12660681
    [Abstract] [Full Text] [Related]

  • 8. [The effect of one year of recombinant human growth hormone (rhGH) therapy on left ventricle structure and function in adults with severe growth hormone deficiency].
    Płońska E, Krzyzanowska-Swiniarska B, Gruszczyńska M, Pynka S, Lewandowski M, Kornacewicz-Jach Z, Pilarska K.
    Pol Merkur Lekarski; 2006 Apr; 20(118):386-9. PubMed ID: 16886557
    [Abstract] [Full Text] [Related]

  • 9. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R, Gunczler P, Lopez E, Esaa S, Villaroel O, Revel-Chion R.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [Abstract] [Full Text] [Related]

  • 10. Growth Hormone Improves Cardiopulmonary Capacity and Body Composition in Children With Growth Hormone Deficiency.
    Capalbo D, Barbieri F, Improda N, Giallauria F, Di Pietro E, Rapacciuolo A, Di Mase R, Vigorito C, Salerno M.
    J Clin Endocrinol Metab; 2017 Nov 01; 102(11):4080-4088. PubMed ID: 28938456
    [Abstract] [Full Text] [Related]

  • 11. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A, Gryczynska M, Ziemnicka K, Czepczynski R, Sowinski J, Wysocki H.
    Growth Horm IGF Res; 2005 Apr 01; 15(2):156-64. PubMed ID: 15809020
    [Abstract] [Full Text] [Related]

  • 12. Echocardiographic evaluation of systolic and diastolic left ventricular function following arterial switch operation in the neonatal period for transposition of the great arteries. Midterm results.
    Crepaz R, Secchieri S, Svaluto G, Milanesi O, Pitscheider W, Gentili L, Rubino M, Stellin G.
    G Ital Cardiol; 1997 Mar 01; 27(3):224-30. PubMed ID: 9199950
    [Abstract] [Full Text] [Related]

  • 13. Subtle alterations of cardiac performance in children with growth hormone deficiency: results of a two-year prospective, case-control study.
    Capalbo D, Lo Vecchio A, Farina V, Spinelli L, Palladino A, Tiano C, Lettiero T, Lombardi G, Colao A, Salerno M.
    J Clin Endocrinol Metab; 2009 Sep 01; 94(9):3347-55. PubMed ID: 19584193
    [Abstract] [Full Text] [Related]

  • 14. The influence of growth hormone therapy on ultrasound myocardial tissue characterization in patients with childhood onset GH deficiency.
    Minczykowski A, Gryczynska M, Ziemnicka K, Sowinski J, Wysocki H.
    Int J Cardiol; 2005 May 25; 101(2):257-63. PubMed ID: 15882673
    [Abstract] [Full Text] [Related]

  • 15. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F.
    Clin Endocrinol (Oxf); 2004 May 25; 60(5):568-75. PubMed ID: 15104559
    [Abstract] [Full Text] [Related]

  • 16. [The effect of one year therapy with recombinant human growth hormone (rhGH) on growth velocity, calcium-phosphorus metabolism, bone mineral density and changes in body composition in children with growth hormone deficiency (GHD)].
    Zak T, Basiak A, Zubkiewicz-Kucharska A, Noczyńska A.
    Pediatr Endocrinol Diabetes Metab; 2010 May 25; 16(1):39-43. PubMed ID: 20529605
    [Abstract] [Full Text] [Related]

  • 17. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG.
    Growth Horm IGF Res; 2008 Aug 25; 18(4):318-24. PubMed ID: 18289903
    [Abstract] [Full Text] [Related]

  • 18. Recombinant human growth hormone secreted from tissue-engineered bioartificial muscle improves left ventricular function in rat with acute myocardial infarction.
    Rong SL, Wang YJ, Wang XL, Lu YX, Chang C, Wang FZ, Liu QY, Liu XY, Gao YZ, Mi SH.
    Chin Med J (Engl); 2009 Oct 05; 122(19):2352-9. PubMed ID: 20079139
    [Abstract] [Full Text] [Related]

  • 19. M-mode echocardiographic evaluation of systolic function, LV volume and mass in children on growth hormone therapy.
    Stamoyannou L, Georgacopoulos D, Trapali C, Neou P, Bartsocas CS, Margetakis A.
    J Pediatr Endocrinol Metab; 2000 Feb 05; 13(2):157-61. PubMed ID: 10711660
    [Abstract] [Full Text] [Related]

  • 20. Recombinant human growth hormone treatment for dilated cardiomyopathy in children.
    McElhinney DB, Colan SD, Moran AM, Wypij D, Lin M, Majzoub JA, Crawford EC, Bartlett JM, McGrath EA, Newburger JW.
    Pediatrics; 2004 Oct 05; 114(4):e452-8. PubMed ID: 15466071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.